Skip to main content
. 2015 Nov 11;8:3329–3336. doi: 10.2147/OTT.S89241

Figure 3.

Figure 3

In the third-line cetuximab group, Kaplan–Meier curves of OS and PFS are illustrated stratified by with or without prior bevacizumab.

Notes: (A) OS for patients receiving cetuximab as third line. (B) PFS for patients receiving cetuximab as third line.

Abbreviations: OS, overall survival; PFS, progression-free survival.